GENE ONLINE|News &
Opinion
Blog

acquisition
Ajinomoto to Acquire Forge Biologics for $620 Million to Boost Gene Therapy Capabilities
2023-11-14
Strides Pharma to Sell Manufacturing Facility in Cost Optimization Move
2023-10-31
Novo Nordisk Acquires Ocedurenone with $1.3B for Hypertension and Cardiovascular Disease
2023-10-18
Kyowa Kirin to Acquire Orchard Therapeutics, Forging a Path in Genetic Medicine
2023-10-11
Danaher Acquires Abcam for $5.7 Billion
2023-08-31
Novo Nordisk Delivers Strong H1 Financial Performance, With Acquisition to Expand Weight Loss Market
2023-08-16
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
GeneOnline’s Weekly News Highlights: July 10-14
2023-07-17
Astellas Trains Sights On Iveric Bio In $5.9 Billion Acquisition
2023-05-03
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Prenetics Announces Acquisition of ACT Genomics, Aiming for the Multi-billion Market of Precision Oncology
2022-12-21
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
Thermo Fisher Announces the Multi-Billion Dollar Acquisition of The Binding Site Group
2022-10-31
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
1 2
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top